SAB4200818
Anti- Proteus mirabilis antibody produced in rabbit
IgG fraction of antiserum
Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
NACRES:
NA.41
UNSPSC Code:
12352203
Product Name
Anti- Proteus mirabilis antibody produced in rabbit, IgG fraction of antiserum
biological source
rabbit
antibody form
IgG fraction of antiserum
clone
polyclonal
description
Research area: Microbiome
form
buffered aqueous solution
mol wt
~70 kDa
species reactivity
Proteus mirabilis
packaging
antibody small pack of 25 μL
concentration
~1 mg/mL
technique(s)
immunoblotting: 1:10,000-1:20,000 using Proteus mirabilis LPS
indirect ELISA: 1:16,000-1:32,000
shipped in
dry ice
storage temp.
−20°C
target post-translational modification
unmodified
Related Categories
Application
Anti-Proteus mirabilis antibody recognizes P. mirabilis whole extract and P. mirabilis LPS, the antibody also recognizes an additional ~70kDa band suspected as bacterial HSP70 (DNAK) in whole extract P. vulgaris, P. gingivalis, E.coli K-12, P.aeruginosa, S. flexneri, S. enterica and E. faecalis but it has no cross reactivity with P. vulgaris LPS. The antibody may be used in various immunochemical techniques including Immunoblotting and ELISA.
Disclaimer
This product is for R&D use only, not for drug, household, or other uses.
General description
Proteus mirabilis is a Gram negative rod-shaped bacteria, belongs to the Enterobacteriaceae family. Member of the Proteus genus (Proteus spp.) which also includes Proteus mirabilis, Proteus penneri and Proteus hauseri, originally characterize by their ability to swarm on solid surfaces, are widespread in the environment and the gastrointestinal tract of human and animals and known to be an opportunistic pathogens isolated from urine, wounds and other clinical sources. The Proteus spp. bacteria, are distinguished by their reactions for indole production, salicin fermentation and aesculin hydrolysis. P. vulgaris produces indole which differentiates it from the indole-negative P. mirabilis and P. penneri. Proteus spp. bacteria may also be found in soil or water habitats where they often regarded as indicators of fecal pollution and a contamination threat for potential water or seafood poisoning.
Immunogen
Proteus mirabilis OXK dead bacteria, ATCC strain 15146
Other Notes
This product is for R&D use only, not for drug, household, or other uses.
Physical form
Supplied as a solution in 0.01 M phosphate buffered saline pH 7.4, containing 15 mM sodium azide as a preservative.
Storage Class
10 - Combustible liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
常规特殊物品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Noriyuki Nagano et al.
Journal of clinical microbiology, 41(12), 5530-5536 (2003-12-10)
Nineteen multidrug-resistant Proteus mirabilis strains were isolated from 19 patients suffering from infections probably caused by P. mirabilis. These strains were recovered from urine or other urogenital specimens of 16 inpatients and three outpatients with a hospitalization history in a
ANTIMICROBIAL RESISTANCE PATTERNS OF PROTEUS ISOLATES FROM CLINICAL SPECIMENS
Bahashwan, et al.
EUROPEAN SCIENTIFIC JOURNAL, 9, 188-202 (2013)
C M O'Hara et al.
International journal of systematic and evolutionary microbiology, 50 Pt 5, 1869-1875 (2000-10-18)
Strains traditionally identified as Proteus vulgaris formed three biogroups. Biogroup 1, characterized by negative reactions for indole production, salicin fermentation and aesculin hydrolysis, is now known as Proteus penneri. Biogroup 2, characterized by positive reactions for indole, salicin and aesculin
Dominika Drzewiecka
Microbial ecology, 72(4), 741-758 (2016-10-27)
Proteus spp. bacteria were first described in 1885 by Gustav Hauser, who had revealed their feature of intensive swarming growth. Currently, the genus is divided into Proteus mirabilis, Proteus vulgaris, Proteus penneri, Proteus hauseri, and three unnamed genomospecies 4, 5
N Pal et al.
Annals of medical and health sciences research, 6(5), 267-273 (2017-05-16)
Proteus species cause a variety of community- and hospital-acquired illnesses. Synthesis of β-lactamases is the predominant mechanism for resistance to β-lactam antibiotics. Among the β-lactamases, extended spectrum β-lactamases (ESBLs) and AmpC β-lactamases are the most common. The objective of this
Related Content
Instructions
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service